Is antibiotics use really associated with increased risk of colorectal cancer? An updated systematic review and meta-analysis of observational studies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is antibiotics use really associated with increased risk of colorectal cancer? An updated systematic review and meta-analysis of observational studies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Volume 35, Issue 8, Pages 1397-1412
Publisher
Springer Science and Business Media LLC
Online
2020-06-06
DOI
10.1007/s00384-020-03658-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association between colorectal cancer and prior antibiotic prescriptions: case control study
- (2020) David Armstrong et al. BRITISH JOURNAL OF CANCER
- Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants
- (2020) Qian-Yi Wan et al. GUT
- Quinolone hybrids and their anti-cancer activities: An overview
- (2019) Feng Gao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo
- (2019) Fangbing Liu et al. Targeted Oncology
- Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989–2012: a matched case–control study
- (2019) Jiajia Zhang et al. GUT
- Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
- (2019) Fausto Petrelli et al. Cancers
- Antibiotic exposure and the risk of colorectal adenoma and carcinoma: a systematic review and meta‐analysis of observational studies
- (2019) L. N. Sanyaolu et al. Colorectal Disease
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
- (2018) Farhad Ravandi et al. HAEMATOLOGICA
- Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
- (2018) Farhad Ravandi et al. HAEMATOLOGICA
- Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories
- (2018) Kyle J Foreman et al. LANCET
- Gut microbiota and colorectal cancer
- (2017) R. Gao et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Microbiota, Inflammation and Colorectal Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Quinolones in the Search for New Anticancer Agents
- (2016) Pedro Batalha et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
- (2016) Gene C. Jamieson et al. DRUGS
- Antibiotics as deep modulators of gut microbiota: between good and evil
- (2016) Gianluca Ianiro et al. GUT
- The microbiota in adaptive immune homeostasis and disease
- (2016) Kenya Honda et al. NATURE
- Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens
- (2016) Eric G. Pamer SCIENCE
- The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
- (2016) Amy Langdon et al. Genome Medicine
- Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
- (2016) Kosuke Mima et al. Clinical and Translational Gastroenterology
- Antibiotics and the developing infant gut microbiota and resistome
- (2015) Molly K Gibson et al. CURRENT OPINION IN MICROBIOLOGY
- Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case–Control Study
- (2015) Vincent K. Dik et al. DIGESTIVE DISEASES AND SCIENCES
- Colorectal cancer
- (2015) Herb Brody NATURE
- Impact of antibiotic exposure on the risk of colorectal cancer
- (2015) Ben Boursi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Colorectal cancer
- (2015) Ernst J. Kuipers et al. Nature Reviews Disease Primers
- Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case-control study in patients with Type 2 diabetes mellitus
- (2014) Jiun-Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea
- (2014) Henrik Knecht et al. PLoS One
- Disruption of the gut microbiome as a risk factor for microbial infections
- (2013) Arya Khosravi et al. CURRENT OPINION IN MICROBIOLOGY
- The gut microbiota — masters of host development and physiology
- (2013) Felix Sommer et al. NATURE REVIEWS MICROBIOLOGY
- Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity
- (2009) Gary D. Friedman et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of Exposure of Clostridium difficile PCR Ribotypes 027 and 001 to Fluoroquinolones in a Human Gut Model
- (2008) K. Saxton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic use predicts an increased risk of cancer
- (2008) Annamari Kilkkinen et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search